FindTrial
Sign In

Establishment and clinical application evaluation of multidimensional molecular detection system for glioma based on NGS platform

Establishment and clinical application evaluation of multidimensional molecular detection system for glioma based on NGS platform

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047808
Enrollment
Unknown
Registered
2021-06-26
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

case series:no

Sponsors

The First Affiliated Hospital of PLA Army Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years; 2. Patients with glioma diagnosed by pathology and complete clinical follow-up data.

Exclusion criteria

Exclusion criteria: Patients who have previously received a bone marrow or stem cell transplant.

Design outcomes

Primary

MeasureTime frame
NGS detection of glioma;NGS detection of glioma methylation;—

Countries

China

Contacts

Public ContactYan Xiaochu

The First Affiliated Hospital of PLA Army Medical University

yxcwq@163.com+86 13983765723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026